Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. / Løland, Claus Juul; Desai, Rajeev I; Zou, Mu-Fa; Cao, Jianjing; Grundt, Peter; Gerstbrein, Klaus; Sitte, Harald H; Newman, Amy Hauck; Katz, Jonathan L; Gether, Ulrik.
In: Molecular Pharmacology, Vol. 73, No. 3, 2007, p. 813-23.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
AU - Løland, Claus Juul
AU - Desai, Rajeev I
AU - Zou, Mu-Fa
AU - Cao, Jianjing
AU - Grundt, Peter
AU - Gerstbrein, Klaus
AU - Sitte, Harald H
AU - Newman, Amy Hauck
AU - Katz, Jonathan L
AU - Gether, Ulrik
N1 - Keywords: Alanine; Amino Acid Substitution; Animals; Biological Transport; COS Cells; Cercopithecus aethiops; Cocaine; Data Interpretation, Statistical; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Male; Mesylates; Motor Activity; Protein Binding; Protein Conformation; Rats; Rats, Sprague-Dawley; Transfection
PY - 2007
Y1 - 2007
N2 - Cocaine exerts its stimulatory effect by inhibiting the dopamine transporter (DAT). However, novel benztropine- and rimcazole-based inhibitors show reduced stimulant effects compared with cocaine, despite higher affinity and selectivity for DAT. To investigate possible mechanisms, we compared the subjective effects of different inhibitors with their molecular mode of interaction at the DAT. We determined how different inhibitors affected accessibility of the sulfhydryl-reactive reagent [2-(trimethylammonium)ethyl]-methanethiosulfonate to an inserted cysteine (I159C), which is accessible when the extracellular transporter gate is open but inaccessible when it is closed. The data indicated that cocaine analogs bind an open conformation, whereas benztropine and rimcazole analogs bind a closed conformation. Next, we investigated the changes in inhibition potency of [(3)H]dopamine uptake of the compounds at a mutant DAT (Y335A) characterized by a global change in the conformational equilibrium. We observed a close relationship between the decrease in potencies of inhibitors at this mutant and cocaine-like responding in rats trained to discriminate cocaine from saline injections. Our data suggest that chemically different DAT inhibitors stabilize distinct transporter conformations and that this in turn affects the cocaine-like subjective effects of these compounds in vivo.
AB - Cocaine exerts its stimulatory effect by inhibiting the dopamine transporter (DAT). However, novel benztropine- and rimcazole-based inhibitors show reduced stimulant effects compared with cocaine, despite higher affinity and selectivity for DAT. To investigate possible mechanisms, we compared the subjective effects of different inhibitors with their molecular mode of interaction at the DAT. We determined how different inhibitors affected accessibility of the sulfhydryl-reactive reagent [2-(trimethylammonium)ethyl]-methanethiosulfonate to an inserted cysteine (I159C), which is accessible when the extracellular transporter gate is open but inaccessible when it is closed. The data indicated that cocaine analogs bind an open conformation, whereas benztropine and rimcazole analogs bind a closed conformation. Next, we investigated the changes in inhibition potency of [(3)H]dopamine uptake of the compounds at a mutant DAT (Y335A) characterized by a global change in the conformational equilibrium. We observed a close relationship between the decrease in potencies of inhibitors at this mutant and cocaine-like responding in rats trained to discriminate cocaine from saline injections. Our data suggest that chemically different DAT inhibitors stabilize distinct transporter conformations and that this in turn affects the cocaine-like subjective effects of these compounds in vivo.
U2 - 10.1124/mol.107.039800
DO - 10.1124/mol.107.039800
M3 - Journal article
C2 - 17978168
VL - 73
SP - 813
EP - 823
JO - Molecular Pharmacology
JF - Molecular Pharmacology
SN - 0026-895X
IS - 3
ER -
ID: 5772532